Wordt geladen...
Current Status of Autologous Stem Cell Transplantation in Relapsed and Refractory Hodgkin's Lymphoma
Despite the relatively high long-term disease-free survival (DFS) rate for patients with Hodgkin lymphoma (HL) with modern combination chemotherapy or combined modality regimens, ∼20% of patients die from progressive or relapsed disease. The standard treatment for relapsed and primary refractory HL...
Bewaard in:
| Hoofdauteurs: | , , |
|---|---|
| Formaat: | Artigo |
| Taal: | Inglês |
| Gepubliceerd in: |
AlphaMed Press
2012
|
| Onderwerpen: | |
| Online toegang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3267827/ https://ncbi.nlm.nih.gov/pubmed/22210089 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1634/theoncologist.2011-0177 |
| Tags: |
Voeg label toe
Geen labels, Wees de eerste die dit record labelt!
|